BDBM107704 US11426393, Compound Table XV.11::US8598210, 119::US8598210, Table XV, 10::US8598210, Table XV, 11::US8722895, 10: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid trifluoroacetic acid salt::US8722895, 11: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US9598370, Example 00136::USRE47437, Example {[5-(3-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid
SMILES OC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1
InChI Key InChIKey=JGRXMPYUTJLTKT-UHFFFAOYSA-N
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 107704
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Akebia Therapeutics
US Patent
Akebia Therapeutics
US Patent
Affinity DataEC50: 7.60E+3nMAssay Description:HEK293 cells are seeded in 96-well poly-lysine coated plates at 20,000 ceils per well in DMEM (10% FBS, 1% NEAA, 0.1% glutamine). Following overnight...More data for this Ligand-Target Pair